PZ Cussons plc (LON:PZC - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 80.89 ($1.10) and traded as high as GBX 87.60 ($1.19). PZ Cussons shares last traded at GBX 86.30 ($1.17), with a volume of 240,339 shares changing hands.
PZ Cussons Price Performance
The company has a current ratio of 1.18, a quick ratio of 1.36 and a debt-to-equity ratio of 73.75. The business has a 50-day moving average of GBX 81.12 and a 200 day moving average of GBX 80.96. The firm has a market capitalization of £335.49 million, a PE ratio of -5.90, a price-to-earnings-growth ratio of 1.13 and a beta of 0.26.
PZ Cussons Company Profile
(
Get Free Report)
PZ Cussons plc manufactures, distributes, markets, and sells baby, beauty, and hygiene products in Europe, the Americas, the Asia Pacific, and Africa. The company offers toiletries, pharmaceuticals, electrical goods, edible oils, fats and spreads, nutritional products, shampoos, body washes, toothpastes, toothbrushes, skin and hair care products, food pouches, cereals, snacks, flavors, and fragrances; beauty soaps, lotions, wipes, creams, shower gels, foam-bursts, bar soaps, deodorants, bath infusions, handwashes, and conditioners; ointments; dishwashing liquids, dishwasher tablets, dishwasher gels, dishwasher capsules, rinse aids, liquid detergents, laundry soaps, and laundry solutions; and cooking and vegetable oils.
Read More
Before you consider PZ Cussons, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PZ Cussons wasn't on the list.
While PZ Cussons currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
